Published in Mol Cell Neurosci on December 26, 2006
Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neurosci (2009) 1.00
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. J Biol Chem (2011) 0.96
Slow intracellular accumulation of GABA(A) receptor delta subunit is modulated by brain-derived neurotrophic factor. Neuroscience (2009) 0.96
Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience (2010) 0.95
Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate. Br J Pharmacol (2010) 0.92
Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology (2008) 0.88
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology (2008) 0.88
Rab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells. Neurosci Lett (2009) 0.87
Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics (2009) 0.85
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. J Biol Chem (2011) 0.81
Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization. J Biol Chem (2013) 0.79
Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis. J Neurochem (2010) 0.79
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78
Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops. Biochim Biophys Acta (2015) 0.77
Upregulation of norepinephrine transporter function by prolonged exposure to nicotine in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.77
Ca(2+) dependent surface trafficking of norepinephrine transporters depends on threonine 30 and Ca(2+) calmodulin kinases. J Chem Neuroanat (2016) 0.75
Stimulation of norepinephrine transporter function by fasudil, a Rho kinase inhibitor, in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75
Store-operated calcium channels. Physiol Rev (2005) 11.95
Neurotoxins affecting neuroexocytosis. Physiol Rev (2000) 5.42
Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell (2003) 4.94
The syntaxin family of vesicular transport receptors. Cell (1993) 4.14
Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (1991) 3.46
SNARE complex formation is triggered by Ca2+ and drives membrane fusion. Cell (1999) 3.04
Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release. Neuron (1998) 2.68
Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins. J Biol Chem (1995) 2.68
Ca2+ regulates the interaction between synaptotagmin and syntaxin 1. J Biol Chem (1995) 2.54
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53
Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes. Mol Cell (1999) 2.22
Calcium-dependent interaction of N-type calcium channels with the synaptic core complex. Nature (1996) 2.03
Munc13-1 acts as a priming factor for large dense-core vesicles in bovine chromaffin cells. EMBO J (2000) 1.98
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci (2000) 1.93
Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem (2004) 1.66
Novel "nonkinase" phorbol ester receptors: the C1 domain connection. Mol Pharmacol (2002) 1.66
Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: its implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin. J Biol Chem (1996) 1.65
Functional co-localization of transfected Ca(2+)-stimulable adenylyl cyclases with capacitative Ca2+ entry sites. J Biol Chem (1996) 1.64
Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci (1997) 1.60
A novel ubiquitous form of Munc-18 interacts with multiple syntaxins. Use of the yeast two-hybrid system to study interactions between proteins involved in membrane traffic. J Biol Chem (1995) 1.57
Regulating the conducting states of a mammalian serotonin transporter. Neuron (2003) 1.55
Timing of synaptic transmission. Annu Rev Physiol (1999) 1.50
A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci (2003) 1.35
Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem Res (2004) 1.35
Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J Biol Chem (2004) 1.32
Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry (1999) 1.30
Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci (2006) 1.18
Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther (1998) 1.17
Regulation of the serotonin transporter by interacting proteins. Biochem Soc Trans (2001) 1.17
Phosphorylation of the synaptic protein interaction site on N-type calcium channels inhibits interactions with SNARE proteins. J Neurosci (1997) 1.15
The secretory granule protein syncollin binds to syntaxin in a Ca2(+)-sensitive manner. Cell (1997) 1.11
Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J Pharmacol Exp Ther (2001) 1.10
Ca2+-dependent phosphorylation of syntaxin-1A by the death-associated protein (DAP) kinase regulates its interaction with Munc18. J Biol Chem (2003) 1.07
Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J Biol Chem (2006) 1.04
Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J Neurosci (1998) 1.00
Regulation of exocytosis through Ca2+/ATP-dependent binding of autophosphorylated Ca2+/calmodulin-activated protein kinase II to syntaxin 1A. J Neurosci (2002) 1.00
Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension (1981) 0.97
Cloning of a novel gene in the human kidney homologous to rat munc13s: its potential role in diabetic nephropathy. Kidney Int (1998) 0.94
Calcium- and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2. J Biol Chem (2001) 0.90
Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother (2003) 0.89
Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology (1996) 0.89
Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Mol Cell Neurosci (2003) 0.88
Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept (1998) 0.88
Ca2+ entry in CHO cells, after Ca2+ stores depletion, is mediated by arachidonic acid. Cell Calcium (1998) 0.87
Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Neuroscience (2006) 0.87
Ca(2+)-dependent enhancement of [3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases. Brain Res (1998) 0.86
Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs. Biol Psychiatry (2003) 0.84
Ca(2+)-dependent enhancement of [3H]dopamine uptake in rat striatum: possible involvement of calmodulin-dependent kinases. J Neurochem (1995) 0.83
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol (1992) 0.82
Third-generation antidepressants: do they offer advantages over the SSRIs? CNS Drugs (2001) 0.81
Possible involvement of calmodulin-dependent kinases in Ca(2+)-dependent enhancement of [3H]5-hydroxytryptamine uptake in rat cortex. Brain Res (1996) 0.80
Differential regulation of mammalian brain-specific proline transporter by calcium and calcium-dependent protein kinases. Br J Pharmacol (2000) 0.78
Role of Ca(2+) and protein kinase C in the serotonin (5-HT) transport in human platelets. Cell Calcium (2002) 0.78
Manic-depression and the norepinephrine transporter gene. Hum Hered (1995) 0.78
Role of Ca2+ and calmodulin-dependent enzymes in the regulation of glycine transport in Müller glia. J Neurochem (2002) 0.77
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology (2006) 2.12
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem (2005) 2.03
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 2.01
Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A (2005) 1.98
Targeting cell surface receptors with ligand-conjugated nanocrystals. J Am Chem Soc (2002) 1.82
p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem (2005) 1.71
Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem (2003) 1.70
Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol (2005) 1.67
Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J Biol Chem (2003) 1.60
Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol (2004) 1.57
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57
Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A (2005) 1.53
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A (2012) 1.48
Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A (2004) 1.46
Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci (2003) 1.45
Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. J Neurosci (2007) 1.43
Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology (2004) 1.42
Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci (2008) 1.41
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci U S A (2009) 1.38
A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci (2003) 1.35
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins (2009) 1.32
Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res (2009) 1.32
Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A (2004) 1.29
Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology (2005) 1.29
Going with the flow: trafficking-dependent and -independent regulation of serotonin transport. Traffic (2008) 1.25
Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci (2009) 1.25
Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem (2006) 1.23
Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol Pharmacol (2005) 1.23
A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A (2006) 1.23
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology (2010) 1.22
The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu Rev Pharmacol Toxicol (2002) 1.22
The choline transporter resurfaces: new roles for synaptic vesicles? Mol Interv (2004) 1.22
Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. J Biol Chem (2002) 1.21
Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci U S A (2008) 1.21
The functional impact of SLC6 transporter genetic variation. Annu Rev Pharmacol Toxicol (2007) 1.20
A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci (2012) 1.20
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci (2010) 1.19
Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci (2006) 1.18
Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles. J Neurosci (2006) 1.16
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci (2003) 1.15
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci (2012) 1.14
Developing novel treatments for mood disorders: accelerating discovery. Biol Psychiatry (2002) 1.13
Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neurol (2003) 1.11
Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters. Cardiovasc Res (2004) 1.09
Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area. Synapse (2004) 1.08
Getting the message across: a recent transporter structure shows the way. Neuron (2006) 1.07
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J (2005) 1.07
Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol Pharmacol (2006) 1.06
Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J Neurodev Disord (2009) 1.06
Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation. J Neurosci (2012) 1.04
Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology (2005) 1.04
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proc Natl Acad Sci U S A (2011) 1.03
Defective presynaptic choline transport underlies hereditary motor neuropathy. Am J Hum Genet (2012) 1.03
A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. J Neurochem (2005) 1.02
The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Pflugers Arch (2013) 1.02
Dependence of serotonergic and other nonadrenergic enteric neurons on norepinephrine transporter expression. J Neurosci (2010) 1.01
Dopamine signaling architecture in Caenorhabditis elegans. Cell Mol Neurobiol (2006) 1.01
The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. J Neurosci (2013) 1.00
Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neurosci (2009) 1.00
Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). J Pharmacol Exp Ther (2003) 1.00
Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism. J Neurosci (2008) 1.00
The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. J Neurosci (2006) 0.98
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. J Biol Chem (2010) 0.97
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol Pharmacol (2003) 0.97
Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. J Pharmacol Exp Ther (2007) 0.97
Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. Arch Biochem Biophys (2002) 0.97
cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Mol Brain (2009) 0.97
Bound to be different: neurotransmitter transporters meet their bacterial cousins. Mol Interv (2007) 0.96
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. J Biol Chem (2011) 0.96
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood (2002) 0.96
Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am J Physiol Heart Circ Physiol (2010) 0.95
Overview: a rare opportunity or just one less reason to be depressed. Neuron (2005) 0.94
Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors. Mol Pharmacol (2011) 0.94
Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem (2012) 0.93
Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Ther (2004) 0.92
Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking. J Neurosci (2010) 0.91
Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. Biochem Biophys Res Commun (2005) 0.90
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Neuropharmacology (2005) 0.90
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. J Neurodev Disord (2009) 0.90
Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Ann N Y Acad Sci (2008) 0.90
Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Mol Cell Neurosci (2003) 0.88
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells. Methods Mol Biol (2005) 0.88
Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots. Bioorg Med Chem Lett (2005) 0.88
Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake. ACS Chem Neurosci (2012) 0.87
Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. Eur J Pharmacol (2004) 0.86
Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis. G3 (Bethesda) (2012) 0.86
Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots. Bioorg Med Chem Lett (2007) 0.85
Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J Clin Invest (2016) 0.85
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism (2013) 0.84
Quantum dot ex vivo labeling of neuromuscular synapses. Nano Lett (2008) 0.84
Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Head Neck (2011) 0.84
Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. J Cogn Neurosci (2014) 0.83
Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J Comp Neurol (2003) 0.83
The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Neuropharmacology (2005) 0.83
Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice. Dis Model Mech (2012) 0.82